UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 392

Sortiert nach

Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia

Clinical cancer research, 2013-05, Vol.19 (9), p.2355-2367

2013

Volltextzugriff (PDF)

Novel therapies upon failure of HMA plus venetoclax

Hematology, 2023-12, Vol.2023 (1), p.702

2023

Volltextzugriff (PDF)

Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.71-81

2023

Volltextzugriff (PDF)

Dying a fiery death: pyroptosis in MDS

Blood, 2016-12, Vol.128 (25), p.2875-2877

Walker, Alison R.

2016

Volltextzugriff (PDF)

Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial

JAMA oncology, 2021-02, Vol.7 (2), p.238

2021

Volltextzugriff (PDF)

Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 Expression

Clinical cancer research, 2020-11, Vol.26 (22), p.5852-5859

2020

Volltextzugriff (PDF)

Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML

Investigational new drugs, 2020-04, Vol.38 (2), p.340-349

2020

Volltextzugriff (PDF)

Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study

Leukemia & lymphoma, 2020-01, Vol.61 (2), p.387-396

2020

Volltextzugriff (PDF)

Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia

Leukemia & lymphoma, 2023-12, Vol.64 (13), p.2091-2100

2023

Volltextzugriff (PDF)

Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia

Cancer discovery, 2020-02, Vol.10 (2), p.214-231

2020

Volltextzugriff (PDF)

Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia

Leukemia & lymphoma, 2016-09, Vol.57 (9), p.2100-2108

2016

Volltextzugriff (PDF)

Phase I study of AR-42 and decitabine in acute myeloid leukemia

Leukemia & lymphoma, 2020-05, Vol.61 (6), p.1484-1492

2020

Volltextzugriff (PDF)

Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia

Leukemia research, 2019-10, Vol.85, p.106197-106197, Article 106197

2019

Volltextzugriff (PDF)

Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markers

Journal of the National Comprehensive Cancer Network, 2014-04, Vol.12 (4), p.527

2014

Volltextzugriff (PDF)

The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating Agent

Clinical lymphoma, myeloma and leukemia, 2021-01, Vol.21 (1), p.e76-e83

2021

Volltextzugriff (PDF)

Predictive performance of early warning scores in acute leukemia patients receiving induction chemotherapy

Leukemia & lymphoma, 2018-06, Vol.59 (6), p.1498-1500

2018

Volltextzugriff (PDF)

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Blood advances, 2021-07, Vol.5 (13), p.2775-2787

2021

Volltextzugriff (PDF)

Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients

Hematological oncology, 2022-02, Vol.40 (1), p.115-118

2022

Volltextzugriff (PDF)

Retrospective analysis of bendamustine and rituximab use in indolent and mantle cell non-Hodgkin lymphoma based on initial starting dose

Leukemia & lymphoma, 2017-07, Vol.58 (7), p.1589-1597

2017

Volltextzugriff (PDF)

Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)

Blood advances, 2018-12, Vol.2 (24), p.3608-3617

2018

Volltextzugriff (PDF)

A comparison of toxicities in acute myeloid leukemia patients with and without renal impairment treated with decitabine

Journal of oncology pharmacy practice, 2018-06, Vol.24 (4), p.290-298

2018

Volltextzugriff (PDF)

Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia

Leukemia & lymphoma, 2014-06, Vol.55 (6), p.1304-1308

2014

Volltextzugriff (PDF)

Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia

Leukemia & lymphoma, 2013-09, Vol.54 (9), p.1996-2002

2013

Volltextzugriff (PDF)

A 75-Year-Old Woman With Thoracic Spinal Cord Compression and Chloroma (granulocytic sarcoma)

Seminars in oncology, 2012-12, Vol.39 (6), p.e37-e46

2012

Volltextzugriff (PDF)

Profound Hypogammaglobulinemia 7 Years after Treatment for Indolent Lymphoma

Cancer investigation, 2008-01, Vol.26 (4), p.431-433

2008

Volltextzugriff (PDF)

1 – 25 von 392

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(374)
Mit Volltextzugriff
(346)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(392)
Japanisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(31)
Journal Of Clinical Oncology
(11)
The Lancet
(10)
Leukemia & Lymphoma
(9)
Lancet
(8)
Leukemia & Lymphoma/leukemia And Lymphoma
(7)
Nature Medicine
(6)
Blood Advances
(5)
Cancer Research
(5)
Clinical Infectious Diseases
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia

Novel therapies upon failure of HMA plus venetoclax

Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines

Dying a fiery death: pyroptosis in MDS

Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial

Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 Expression

Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML

Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study

Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia

Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia

Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia

Phase I study of AR-42 and decitabine in acute myeloid leukemia

Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia

Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markers

The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating Agent

Predictive performance of early warning scores in acute leukemia patients receiving induction chemotherapy

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients

Retrospective analysis of bendamustine and rituximab use in indolent and mantle cell non-Hodgkin lymphoma based on initial starting dose

Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)

A comparison of toxicities in acute myeloid leukemia patients with and without renal impairment treated with decitabine

Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia

Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia

A 75-Year-Old Woman With Thoracic Spinal Cord Compression and Chloroma (granulocytic sarcoma)

Profound Hypogammaglobulinemia 7 Years after Treatment for Indolent Lymphoma

Suchergebnisse filtern